Our Therapies

LUMVOA™ Infusion Therapy

veligrotug-vvze

About LUMVOA™ Infusion Therapy

LUMVOA™ (veligrotug-vvze) is a biologic medication known as an insulin-like growth factor-1 receptor (IGF-1R) inhibitor, given as an intravenous (IV) infusion. It is FDA-approved to treat thyroid eye disease (TED) in adults, no matter how active your disease is or how long you have had it.

A full course of LUMVOA™ is one IV infusion every three weeks for a total of five infusions. At Violet Health, our clinical team handles the scheduling, insurance coordination, and monitoring for each visit, so you can focus on your treatment and recovery.

Nurse offering refreshments to a patient

Conditions treated by this therapy

LUMVOA™ is FDA-approved for the treatment of thyroid eye disease (TED) in adults, including both active (early) and chronic (long-standing) disease. Your care team may consider this therapy if you:

  • Are an adult diagnosed with thyroid eye disease
  • Have active or chronic TED, regardless of how long you have had symptoms
  • Experience symptoms such as eye bulging (proptosis), double vision (diplopia), or eye swelling, redness, and pain
  • Are looking for a treatment option that targets the underlying cause of TED rather than only easing symptoms

Your ophthalmologist or endocrinologist will confirm whether LUMVOA™ is right for you before treatment begins.

CIMZIA® infusion medication

LUMVOA™ Price

The cost of prescription medications can vary depending on your insurance coverage. If you're concerned about the price of your medication:

  • Contact your insurance provider to understand your coverage
  • Ask your doctor or pharmacist about lower-cost alternatives
  • Check with the drug manufacturer about financial assistance programs
  • Explore patient assistance options if you're uninsured or underinsured

Remember, many resources exist to help patients access necessary medications. Don't hesitate to ask for help if you're struggling with medication costs. No patient should go without necessary treatment due to financial limitations. If you have questions about financial assistance opportunities, contact a member of our Violet Health team.

What to Expect During LUMVOA™ Infusion Therapy

When you arrive at our Violet Health location, you'll settle into a private, welcoming space designed with your comfort and peace of mind in mind. Before and during your intravenous infusion, our experienced team will:

  • Review your current health status and any symptoms you've noticed
  • Check your vital signs and blood sugar before treatment begins
  • Place your IV using gentle, practiced technique
  • Administer your LUMVOA™ infusion with our nursing team at your side
  • Monitor you closely for any infusion-related reactions
  • Protect your privacy and comfort throughout the visit

LUMVOA™ is given as one infusion every three weeks, for a total of five infusions. Many patients find the visits manageable and appreciate knowing their course of treatment involves only a small number of appointments from start to finish.

LUMVOA™ Side Effects

As with any medication, LUMVOA™ may cause side effects. Being informed helps you know what to watch for and when to contact your healthcare team. Common Side Effects:

  • Muscle cramps
  • Headache
  • Hearing problems
  • High blood sugar (hyperglycemia)
  • Tiredness
  • Diarrhea
  • Ear discomfort
  • Infusion-related reactions
  • Nausea
  • Cold-like symptoms, such as sore throat or stuffy nose
  • Elevated creatine phosphokinase
  • Dry skin
  • High blood pressure

Although rare, serious side effects can occur. Please alert our clinical staff or seek medical attention immediately if you experience any of the following symptoms:

  • Severe hearing problems, including hearing loss that may be permanent — report ringing in the ears, a feeling of fullness, or any loss of hearing right away
  • Worsening of inflammatory bowel disease, including urgent diarrhea, rectal bleeding, or abdominal cramping
  • Infusion reactions, which occurred in about 9% of patients
  • Increased blood sugar, reported in about 12% of patients — your blood sugar is checked before and during treatment, and diabetes management plans may need to be adjusted

Pregnancy warning: Do not use LUMVOA™ if you are pregnant, as it may harm an unborn baby. Use effective birth control before treatment, during treatment, and for six months after your last dose.

LUMVOA™ Infusion Therapy at Violet Health

Your comfort during LUMVOA™ infusion therapy at Violet Health is our priority. Our patients enjoy walk-up parking, complimentary entertainment and snacks, and a team of highly trained providers during each treatment. Plus, Violet Health’s evening and weekend hours and convenient city and rural locations make it easier to schedule your appointments.

Patient Forms

Before you attend your first appointment at Violet Health, please make sure to review the documents below. Please contact us if you have any questions!

patient form
1

Patient Consent Form

2

HIPAA Privacy Authorization Form

3

Notice of Privacy Practices

4

Patient Rights and Responsibilities

5

Appointment Lateness and Cancelation

Meet our Infusion Specialists

  • Jalal Thwainey M.D.- Medical Director at Violet Health Infusion Care

    Jalal Thwainey M.D.

    Medical Director

  • Emilie Wojcik Nurse Practitioner- Director of Clinical Services at Violet Health Infusions

    Emilie Wojcik, N.P.

    Director of Clinical Services

For Provider

Simplify patient referrals and offer advanced treatment options with our infusion partnership program.

For Patient

There may be a better way to manage your condition – explore infusion therapy.